Y-mAbs Therapeutics, Inc. financial data

Location
Princeton, NJ
Fiscal year end
31 December
Latest financial report
10-Q - Q2 2025 - 08 Aug 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 418% % -6.6%
Quick Ratio 38% % 34%
Debt-to-equity 30% % -6.9%
Return On Equity -25% % 1.2%
Return On Assets -19% % -0.53%
Operating Margin -31% % 2.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 45,438,420 shares 1.9%
Common Stock, Shares, Outstanding 45,438,420 shares 2%
Entity Public Float $450,000,000 USD 83%
Common Stock, Value, Issued $5,000 USD 25%
Weighted Average Number of Shares Outstanding, Basic 45,318,028 shares 2.9%
Weighted Average Number of Shares Outstanding, Diluted 45,318,028 shares 2.9%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $85,385,000 USD -1.3%
Research and Development Expense $45,845,000 USD -16%
Costs and Expenses $96,483,000 USD -1.3%
Operating Income (Loss) $26,651,000 USD 3.6%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $22,617,000 USD 5.6%
Income Tax Expense (Benefit) $394,000 USD -161%
Net Income (Loss) Attributable to Parent $22,223,000 USD 9.7%
Earnings Per Share, Basic 0 USD/shares 11%
Earnings Per Share, Diluted 0 USD/shares 11%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $62,293,000 USD -20%
Accounts Receivable, after Allowance for Credit Loss, Current $15,740,000 USD -29%
Inventory, Net $9,719,000 USD 14%
Other Assets, Current $4,035,000 USD 80%
Assets, Current $91,787,000 USD -28%
Property, Plant and Equipment, Net $269,000 USD 209%
Operating Lease, Right-of-Use Asset $3,109,000 USD 145%
Intangible Assets, Net (Excluding Goodwill) $2,177,000 USD -11%
Other Assets, Noncurrent $646,000 USD -95%
Assets $117,211,000 USD -19%
Accounts Payable, Current $7,571,000 USD -26%
Accrued Liabilities, Current $14,888,000 USD 16%
Liabilities, Current $22,945,000 USD -47%
Operating Lease, Liability, Noncurrent $2,638,000 USD 511%
Other Liabilities, Noncurrent $935,000 USD 10%
Liabilities $29,718,000 USD -39%
Accumulated Other Comprehensive Income (Loss), Net of Tax $612,000 USD -158%
Retained Earnings (Accumulated Deficit) $495,571,000 USD -4.7%
Stockholders' Equity Attributable to Parent $87,493,000 USD -8.2%
Liabilities and Equity $117,211,000 USD -19%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $6,911,000 USD -99%
Net Cash Provided by (Used in) Financing Activities $114,000 USD -81%
Net Cash Provided by (Used in) Investing Activities $127,000 USD
Common Stock, Shares Authorized 100,000,000 shares 0%
Common Stock, Shares, Issued 45,438,420 shares 2%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $6,924,000 USD -140%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $62,293,000 USD -20%
Deferred Tax Assets, Valuation Allowance $151,191,000 USD 1.5%
Operating Lease, Liability $3,124,000 USD 145%
Payments to Acquire Property, Plant, and Equipment $127,000 USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $23,882,000 USD 3%
Lessee, Operating Lease, Liability, to be Paid $4,446,000 USD 223%
Operating Lease, Liability, Current $486,000 USD -42%
Lessee, Operating Lease, Liability, to be Paid, Year Two $382,000 USD 104%
Lessee, Operating Lease, Liability, to be Paid, Year One $533,000 USD -22%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure -12%
Deferred Income Tax Expense (Benefit) $0 USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1,322,000 USD 1209%
Lessee, Operating Lease, Liability, to be Paid, Year Three $372,000 USD 2225%
Deferred Tax Assets, Operating Loss Carryforwards $83,233,000 USD -0.01%
Preferred Stock, Shares Issued 0 shares
Current Income Tax Expense (Benefit) $394,000 USD -93%
Preferred Stock, Shares Authorized 5,500,000 shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four $377,000 USD
Operating Lease, Payments $982,000 USD -6.4%
Additional Paid in Capital $583,671,000 USD 2.8%
Depreciation, Depletion and Amortization $71,000 USD -55%
Share-based Payment Arrangement, Expense $13,517,000 USD 5.5%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%